Showing results (1-10 of 171) with videos related to
Sort By:
Pageof 18
Arteriosclerosis, Thrombosis, and Vascular Biology|January 9, 2001
Circulating autoantibodies to oxidized LDL correlate with arterial accumulation and depletion of oxidized LDL in LDL receptor-deficient miceS Tsimikas, W Palinski, J L WitztumArteriosclerosis, Thrombosis, and Vascular Biology|March 11, 2000
In vivo uptake of radiolabeled MDA2, an oxidation-specific monoclonal antibody, provides an accurate measure of atherosclerotic lesions rich in oxidized LDL and is highly sensitive to their regressionS Tsimikas, B P Shortal, J L Witztum, et al.Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|March 10, 1999
Radiolabeled MDA2, an oxidation-specific, monoclonal antibody, identifies native atherosclerotic lesions in vivoS Tsimikas, W Palinski, S E Halpern, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|August 11, 2001
Human-derived anti-oxidized LDL autoantibody blocks uptake of oxidized LDL by macrophages and localizes to atherosclerotic lesions in vivoP X Shaw, S Hörkkö, S Tsimikas, et al.Circulation|November 1, 1989
Current approaches to drug therapy for the hypercholesterolemic patientJ L WitztumTrends in Cardiovascular Medicine|November 1, 2001
The oxidative modification hypothesis of atherosclerosis: does it hold for humans?J L Witztum, D SteinbergThe Journal of Clinical Investigation|December 1, 1991
Role of oxidized low density lipoprotein in atherogenesisJ L Witztum, D SteinbergDiabetes|December 1, 1978
Carbohydrate diet-induced changes in very low density lipoprotein composition and structureJ L Witztum, G SchonfeldJournal of Internal Medicine|April 13, 2000
Immune responses to oxidative neoepitopes on LDL and phospholipids modulate the development of atherosclerosisW Palinski, J L WitztumPageof 18